Walleye Capital’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-4,400
Closed -$16.4K 5338
2024
Q4
$16.4K Hold
4,400
﹤0.01% 4529
2024
Q3
$24.6K Buy
4,400
+600
+16% +$4.2K ﹤0.01% 4776
2024
Q2
$32K Sell
3,800
-1,800
-32% -$19.2K ﹤0.01% 5037
2024
Q1
$80.9K Buy
+5,600
New +$92.6K ﹤0.01% 4497
2019
Q4
Sell
-3,100
Closed -$267K 2345
2019
Q3
$267K Sell
3,100
-300
-9% -$22.7K 0.02% 1035
2019
Q2
$220K Buy
+3,400
New +$212K 0.02% 918

Other funds holding NVRO

Walleye Capital's NVRO Position: Q2 2025 in Review

Walleye Capital sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 11,436 shares — an estimated $66.8K sold.

Walleye Capital first reported a position in NVRO in Q3 2018 and held it in 19 quarters. The position peaked at $3.85M in Q1 2023. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.

  • Walleye Capital reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
  • Walleye Capital sold 11,436 NEVRO CORP. shares in Q2 2025, an estimated $66.8K.
  • Walleye Capital first reported a position in NEVRO CORP. in Q3 2018 and held it in 19 quarters.
  • Walleye Capital's NEVRO CORP. position peaked at $3.85M in Q1 2023.
  • 1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.

Based on Walleye Capital's 13F filing for Q2 2025, filed 13 Aug 2025.